We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.25 | 1.39% | 18.25 | 18.00 | 18.50 | 18.25 | 18.00 | 18.00 | 67,816 | 08:09:48 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 6.43 | 16.64M |
Date | Subject | Author | Discuss |
---|---|---|---|
28/8/2018 07:51 | Rayracs losses and the continued share price growth of Opti are sending him over the edge.......For the good of Rayracs mental stability please ignore his rather silly posts. | greenas1953 | |
28/8/2018 00:03 | Is it jet-lag or has the BB descended into farcical posts. I note elrico no longer posts here, yet his attention is still required by the children. I think i'll go catch up on some much needed sleep. I'm not missing anything here. | incanus | |
27/8/2018 23:41 | You forget, the nhs would fund it. So why don’t they want to fund opti’s wonder product?! Because it wouldn’t do the job! That’s probably why you have bother getting cash hitting the bottom line from contracts! Why wouldn’t the NHS look at LP-LDL? If they did, then there’s a good chance it worked. It’s obvious!! It’s not working or they’d use it to save £millions. They would rather use a pill costing them £millions? Come on, it’s obvious! | rayrac | |
27/8/2018 23:16 | Hey Raywhack, keep up elrico 00:08 (23 hours ago) 'Holy Grail' diet pill could help millions lose weight in middle age. A snip at c£220 per month. | slartybartfaster | |
27/8/2018 22:57 | ray best way to lose pounds buy bpc lol 1000s of them | manc10 | |
27/8/2018 22:53 | gastrick band fitted price 4000 plus vat no mention of slimbiome lol | manc10 | |
27/8/2018 22:52 | BTW US only..how much a week. Bloody hell, you wouldnt able to feed the rest of the family while dieting. lol | slartybartfaster | |
27/8/2018 22:52 | EME? You are joking!? | rayrac | |
27/8/2018 22:51 | Are thick or blind Raywhack, manc has already said elrico posted the it over the weekend you fool. Unlike you, he isn't afraid of posting such info. If your honest you probably found on elrico forum. You much have slipped through the net. Did you see his latest work, about a real oil explorer with real potential, and no bs twitter posts to ramp it. | slartybartfaster | |
27/8/2018 22:49 | showing how much money it cost all that work by you just to be buzzed off again to easy | manc10 | |
27/8/2018 22:24 | So he didn’t, elrico, want the news on this thread...keep it stum! Why, if elrico knew about it, didn't he put up for all to see?! NHS funded probably, for those in need! They wouldn’t fund opti’s so called, product, so why not?! | rayrac | |
27/8/2018 22:21 | you will lose a few pounds with that pill about 80 pounds a week lol its already on elrics blogg meanwhile back at the ranch lol | manc10 | |
27/8/2018 22:17 | No mention of opti’s product...the medical world isn’t interested! Holy grail’ weight-loss pill beats middle-age spread The most effective slimming pill yet helps mature adults shed nine pounds on average By Laura Donnelly, Health Editor, in Munich A BREAKTHROUGH drug that directly targets middle-age spread could help millions of overweight Britons lose weight. Slimmers taking the pills lost three times as much weight as those simply trying to diet and exercise, a landmark trial found. The drug also cut the risk of diabetes by a fifth. Experts hailed the drug, called lorcaserin, as the most effective weight-loss pill yet, suggesting it could help the two in three adults who are currently battling weight problems. The approach could be the “holy grail” in the battle to combat obesity, they said. The American research, which tracked 12,000 obese or overweight adults, found that four in 10 of those taking the drug lost a significant amount of weight over the course of a year. On average, slimmers taking the twice-daily pills lost 9lb – around a dress size for the average woman – while those who stuck to traditional diet plans shed just 3lb. And more than three years after the trial began, those taking the pills had kept the weight off, the study found. Scientists said the drug was an “important milestone” after decades of failed attempts to to develop effective diet medication to combat the growing global obesity epidemic. Until now, drugs that showed early promise have had little success – or been dogged by safety concerns, in particular about potential dangers to the heart. Harvard researchers said their results, presented at the world’s largest cardiac conference, showed for the first time that a drug could cause consistent and sustained weight loss with no such risks. Scientists said the breakthrough was particularly significant because the drug targets signals in the brain that have been linked to weight gain in middle age. The drug works by activating the neurons in the brain that control “satiety” These neurons become less efficient with age, which is believed to be a key cause of middle-age spread. Experts said the new drug – which is currently licensed in the US, and costs around £220 a month – works by reinvigorating the cells, helping people better control their appetite. Eisai, the drug maker, said it was now evaluating the findings, ahead of any application for a European licence. Prof Jason Halford, an obesity expert at the University of Liverpool, said the drug could help millions of Britons if it was given the go-ahead by the NHS. “We don’t have any appetite suppressants available on the NHS. We have a massive great gap between lifestyle modification and surgery. At the moment you either get support and advice, or you get surgery – there is nothing in-between,” he said. “This could be widely prescribed if it is approved by Nice (the National Institute of Health and Care Excellence) in the UK,” he said. The findings, presented at the European Society of Cardiology conference in Munich, and published in the New England Journal of Medicine, yesterday prompted excitement among obesity and cardiac experts. Tam Fry, of the National Obesity Forum, said it was the “holy grail” of anti-obesity medication. The only weight-loss drug currently available on the NHS is orlistat – which stops fat being absorbed into the body. For years, attempts to develop “centrally acting” appetite suppressors – which make people feel they are full more quickly – have been beset with difficulties because until now they have also caused cardiac problems. The findings suggest the new approach is around twice as effective as orlistat, which can have unpleasant side effects. While 21 per cent of those taking orlistat lost at least five per cent of their total body weight after one year, the new trial found 37 per cent of dieters lost this much weight after 12 months on lorcaserin. And those on the new drug also saw the risk of developing diabetes fall by 19 per cent, compared with those given a placebo. Erin Bohula, a cardiovascular medicine and critical care specialist at Harvard’s Brigham and Women’s Hospital and the lead author, said the findings were an “important milestone” after decades of failed attempts to develop a safe drug, while global obesity rates have tripled. “We have been able to demonstrate for the first time in a rigorous, randomised way that this weight loss drug does what it is intended to do without causing an increase in adverse cardiovascular events in a population at higher risk for heart attacks and strokes,” she said. While rates of major cardiac events were almost identical in those taking the drug, compared with the control group, those on the pills saw “small but significant” improvements in several factors linked to heart disease – including blood pressure, heart rate and blood sugar levels, the study found. Prof Jeremy Pearson, associate medical director at the British Heart Foundation, said the findings were “reassuring | rayrac | |
27/8/2018 13:07 | Raywhack, keep setting them up for manc10, he's killing you. lol | slartybartfaster | |
27/8/2018 09:08 | Guru tipster no life lol | manc10 | |
27/8/2018 09:06 | Lacky’s... | rayrac | |
27/8/2018 09:04 | just for dr of science rayrac hxxp://optibiotix.co | manc10 | |
27/8/2018 08:53 | Over 12 weeks? Not likely! A product that had that control over human health would have to go through thorough phase 1/2/3 trials. Pull the other one! Lot of wishful dreaming here? | rayrac | |
26/8/2018 20:11 | They already have a cholesterol and BP product! LPLDL® has been shown in randomised, placebo controlled human intervention studies to deliver tangible health benefits, reducing cardiovascular risk factors and supporting overall heart wellness. These include: • Lower total cholesterol by up to 36.7% • Lower LDL cholesterol by up to 13.9% • Increase HDL cholesterol by up to 6.5% • Lower systolic blood pressure by 5.1% • Be completely safe and well tolerated | asterix96 | |
26/8/2018 14:58 | elrico just posted a very intriguing find which refers to a 2 in 1 pill for cardio. He makes the point OPTI had developed a worlds first, cholesterol and BP product. The article published in the sun says this was discussed at a munich congress. HLH is German. I'm sure elrico is making the appropriate enquiries. | slartybartfaster | |
26/8/2018 14:12 | Parsons, it's been a calculated effort from Monkeywench to destroy this thread. Then when he started sending threats to Elrico, I think that essentially finished it off. Elrico is extremely well researched on OPTI and has created another thread where others have followed, me included. This thread is dead. Probably makes sense for someone with a Premium account to begin another where they're able to ban other Premium trolls. | polus | |
26/8/2018 14:12 | There's nothing to say because the company hasn't released any deal news for two months. Results this week should generate some interest (one way or the other) | someuwin | |
26/8/2018 13:56 | This site is going from BAD to WORSE, pretty well all of the posts this weekend are about infighting between the bulls and bears of the stock. A waste of every-ones time !!! | parsons4 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions